Tripeptide-10 citrulline
Cosmetic ingredientCosmetic signal peptide
Also known as: Decorinyl, orb1943819, GKPMARPRXONRJX-BWJWTDLKSA-N, T80944
Very thin human evidence
- Regulatory standing. Cosmetic ingredient, not regulated as a drug
- Animal / preclinical only. Evidence is largely animal or in-vitro
- No registered human trials. Nothing registered on ClinicalTrials.gov
- 1 cited source. Includes primary / regulatory sources
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
Tripeptide-10 citrulline, sold under the trade name Decorinyl, is a short synthetic peptide used as an ingredient in skin care products. It is designed to mimic a fragment of decorin, a protein that helps organize collagen fibers in skin, and is thought to support more regular collagen fibril structure.
What the evidence shows
There are no registered human clinical trials and only about two published papers, mostly manufacturer-linked or lab-based, so claims about firmness or wrinkle reduction are not well established in humans. It is regulated as a cosmetic ingredient, not an FDA-approved drug.
Key facts
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
Published literature
Live from Europe PMC. This is how much has been published, not how much is proven in humans.
Sources
- PubChem compound record (CID 90479646)
- Registered trials on ClinicalTrials.gov
- Published papers on Europe PMC
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.